Projekt

Randomized study with a run-in feasibility phase to assess the added value of Clofarabine in combination with standard remission-induction chemotherapy in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or myelodysplasia (MDS) (RAEB with IPSS ≥ 1.5)

Abgeschlossen · 2013 bis 2023

Silzle Tobias, Munz Jeannine, Quinter Janine